Clinical Trial Update: A Study of Varlilumab and Atezolizumab in Patients With Advanced Cancer [Phase 1]

View source ↗

Summary

A Phase 1 study evaluating varlilumab in combination with atezolizumab in patients with advanced cancers has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bladder Cancer
• Head and Neck Cancer
• Melanoma
• Non-small Cell Lung Cancer
• Renal Cell Carcinoma
• Triple-negative Breast Cancer

Drugs mentioned

• Atezolizumab (atezolizumab)
• Varlilumab (varlilumab)

Snippet

Sponsor: Celldex Therapeutics | Conditions: Carcinoma, Renal Cell, Kidney Diseases | Phase 1 | Status: TERMINATED